Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
However, substantial heterogeneity across the studies indicated considerable uncertainty in this estimate
In one study, participants regained two-thirds of their previous weight loss within the year after stopping the medication
Back Holst, JJ (26 April 2019) 'From the Incretin Concept and the discovery of GLP-1 to today's diabetes therapy', Frontiers in Endocrinology , 10
The effect of glucagon-like peptide-1 receptor agonists on diabetic retinopathy at a tertiary care center
Administration is once daily
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
